Cyclic amine BACE-1 inhibitors having a benzamide substituent

Details for Australian Patent Application No. 2004265298 (hide)

Owner Pharmacopeia Drug Discovery, Inc. Schering Corporation

Inventors Le, Thuy X. H.; Guo, Tao; Huang, Ying; Cumming, Jared N.; Lowrie, Jeffrey F.; Xia, Yan; Strickland, Corey; Chackalamannil, Samuel; Stamford, Andrew; Wu, Yusheng; Voigt, Johannes H.; Hobbs, Douglas W.; Babu, Suresh D.; Saionz, Kurt W.; Iserloh, Ulrich

Agent Griffith Hack

Pub. Number AU-A-2004265298

PCT Pub. Number WO2005/016876

Priority 60/493,987 08.08.03 US

Filing date 4 August 2004

Wipo publication date 24 February 2005

International Classifications

C07D 403/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/47 (2006.01) - Quinolines

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 31/5355 (2006.01) - Non-condensed oxazines containing further heterocyclic rings

A61K 33/42 (2006.01) Medicinal preparations containing inorganic active ingredients - Phosphorus

C07D 207/09 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 211/26 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 217/18 (2006.01) Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems

C07D 241/04 (2006.01) Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

C07D 243/08 (2006.01) Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 413/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07F 9/38 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

Event Publications

16 February 2006 PCT application entered the National Phase

  PCT publication WO2005/016876 Priority application(s): WO2005/016876

13 September 2007 Assignment before Grant

  Schering Corporation; Pharmacopeia Drug Discovery, Inc. The application has been assigned to Schering Corporation; Pharmacopeia, Inc.

4 March 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004265299-Pyrazole carboxamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1

2004265288-2,4-pyrimidinediamine compounds for use in the treatment or prevention of autoimmune diseases